|
|
Volumn 105, Issue 18, 2002, Pages 2231-2239
|
|
Prevention conference VI: Diabetes and cardiovascular disease - Executive summary: Conference proceeding for healthcare professionals from a special writing group of the American Heart Association
a a a a a a
a
NONE
|
|
Author keywords
AHA Conference Proceedings; Cardiovascular diseases; Diabetes mellitus; Hypertension; Lipoproteins; Myocardial infarction
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANGIOTENSIN 2 RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
ANTILIPEMIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ENGLITAZONE;
HEMOGLOBIN A1C;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
INSULIN;
METFORMIN;
ORAL ANTIDIABETIC AGENT;
STATIN;
SULFONYLUREA DERIVATIVE;
THIAZIDE DIURETIC AGENT;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
CONFERENCE PAPER;
CORONARY ARTERY BYPASS SURGERY;
DIABETES MELLITUS;
DIET;
EPIDEMIOLOGICAL DATA;
EXERCISE TEST;
GLUCOSE METABOLISM;
HEART DEATH;
HEART LEFT VENTRICLE FAILURE;
HUMAN;
HYPERTENSION;
LIPID METABOLISM;
MEDICAL SOCIETY;
MORBIDITY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
NUTRITION;
PATHOGENESIS;
PATHOPHYSIOLOGY;
PHYSICAL ACTIVITY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SCREENING;
SMOKING CESSATION;
TEAMWORK;
AMERICAN HEART ASSOCIATION;
ARTERIOSCLEROSIS;
CLINICAL TRIALS;
DIABETIC ANGIOPATHIES;
DIABETIC NEPHROPATHIES;
HUMANS;
ISCHEMIC PRECONDITIONING, MYOCARDIAL;
LIFE STYLE;
MYOCARDIAL INFARCTION;
MYOCARDIAL REVASCULARIZATION;
PRACTICE GUIDELINES;
RISK ASSESSMENT;
RISK FACTORS;
SODIUM-HYDROGEN ANTIPORTER;
UNITED STATES;
VENTRICULAR DYSFUNCTION, LEFT;
|
|
EID: 0037035456
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/01.CIR.0000013952.86046.DD Document Type: Conference Paper |
|
Times cited : (292)
|
|
References (0)
|